Pharmaceutical companies should rebrand clinical trials to improve public perception of the research process and make better use of the Internet to recruit trial participants, according to a new Datamonitor report. The report says 90% of clinical drug trials are delayed, mostly because of patient recruitment problems.

Full Story:
Healthcare IT News

Related Summaries